cefminox has been researched along with fosfomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murakami, T; Nakagawa, H; Nakai, H; Nishigaki, H; Seriu, T; Takahashi, Y; Takashima, T; Tanaka, S; Tsuda, S; Yokota, S | 1 |
| Anandan, S; Balaji, V; Falagas, ME; Rajenderan, S; Sahni, RD; Tansarli, GS | 1 |
2 other study(ies) available for cefminox and fosfomycin
| Article | Year |
|---|---|
[Clinical evaluation of a combination treatment with cefminox and fosfomycin for infections complicated in patients with hematological disorders].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cephamycins; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Fosfomycin; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Leukemia; Lymphoma; Male; Middle Aged | 1991 |
Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study.
Topics: Acinetobacter; Anti-Bacterial Agents; Cephamycins; Dibekacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Klebsiella; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Thienamycins | 2014 |